Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Sangamo Therapeutics (SGMO) Q2 2024 Earnings
SGMO
9
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.59
-0.46
-0.34
-0.21
Details
Expected EPS
-0.21375
Actual EPS
-0.27
Surprise EPS
-0.06
Surprise Percent
+26.32%
Description
Sangamo Therapeutics (SGMO) has reported earnings of -0.27 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login